2seventy bio Inc (NASDAQ: TSVT) kicked off on Monday, down -5.25% from the previous trading day, before settling in for the closing price of $3.05. Over the past 52 weeks, TSVT has traded in a range of $2.78-$6.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 73.45%. While this was happening, its average annual earnings per share was recorded 81.88%. With a float of $48.33 million, this company’s outstanding shares have now reached $51.51 million.
Let’s determine the extent of company efficiency that accounts for 274 employees. In terms of profitability, gross margin is 51.77%, operating margin of -313.09%, and the pretax margin is -207.25%.
2seventy bio Inc (TSVT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of 2seventy bio Inc is 6.31%, while institutional ownership is 87.83%. The most recent insider transaction that took place on Dec 13 ’24, was worth 7,393. In this transaction an insider of this company sold 2,287 shares at a rate of $3.23, taking the stock ownership to the 153,479 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Officer proposed sale 10,341 for $3.34, making the entire transaction worth $34,539.
2seventy bio Inc (TSVT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.88% per share during the next fiscal year.
2seventy bio Inc (NASDAQ: TSVT) Trading Performance Indicators
Take a look at 2seventy bio Inc’s (TSVT) current performance indicators. Last quarter, stock had a quick ratio of 4.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.86, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of 2seventy bio Inc (TSVT)
Looking closely at 2seventy bio Inc (NASDAQ: TSVT), its last 5-days average volume was 0.6 million, which is a drop from its year-to-date volume of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 38.98%. Additionally, its Average True Range was 0.25.
During the past 100 days, 2seventy bio Inc’s (TSVT) raw stochastic average was set at 4.37%, which indicates a significant decrease from 8.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.83% in the past 14 days, which was lower than the 70.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.93, while its 200-day Moving Average is $4.40. However, in the short run, 2seventy bio Inc’s stock first resistance to watch stands at $2.99. Second resistance stands at $3.10. The third major resistance level sits at $3.17. If the price goes on to break the first support level at $2.81, it is likely to go to the next support level at $2.74. Now, if the price goes above the second support level, the third support stands at $2.63.
2seventy bio Inc (NASDAQ: TSVT) Key Stats
The company with the Market Capitalisation of 148.60 million has total of 51,588K Shares Outstanding. Its annual sales at the moment are 100,390 K in contrast with the sum of -217,570 K annual income. Company’s last quarter sales were recorded 13,530 K and last quarter income was -9,930 K.
